Literature DB >> 1951313

Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT).

K Deguchi1, M Noguchi, E Yuwasaki, T Endou, A Deguchi, H Wada, S Murashima, M Nishikawa, S Shirakawa, K Tanaka.   

Abstract

The dynamic fluctuation of thrombin-antithrombin III complex (TAT) was studied in blood obtained during the daytime (at 9 AM, noon, 3 PM), during extracorporeal circulation and during the course of disseminated intravascular coagulation (DIC), to certify whether the level of TAT in blood can reflect the generation of thrombin. In 10 healthy male volunteers, the mean values of TAT (micrograms/liter) were 1.74 (+/- 1.36) at 9 AM, 1.22 (+/- 0.47) at noon, and 1.25 (+/- 0.68) at 3 PM. TAT did not show a daytime fluctuation, unlike fibrinolytic factors. The mean values of TAT in 38 hemodialyzed patients were 4.83 (+/- 2.8) before the initiation, 6.59 (+/- 4.39) in the first hour, and 13.42 (+/- 10.96) at the end of a dialysis session. In 20 patients undergoing open heart surgery, the mean value of TAT was increased during cardiopulmonary bypass (CPB) and decreased with time after the end of surgery. The fibrinopeptide A (FPA) value was increased with TAT during CPB but achieved a maximum level immediately after heparin neutralization by protamine. In 20 patients with DIC, the values of TAT varied from 5.8 to 297 micrograms/liter in the blood at the onset of DIC. In seven of eight patients treated with low-molecular-weight heparin (LMW-H), the values of TAT and FPA were lower 24 hr after LMW-H than before the treatment. These results suggest that the level of TAT in blood reflected the formation of thrombin and could serve as a sensitive parameter of activated coagulation in circulating blood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1951313     DOI: 10.1002/ajh.2830380203

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  Comparison of the Hemocompatibility of an Axial and a Centrifugal Left Ventricular Assist Device in an In Vitro Test Circuit.

Authors:  Patrick Borchers; Patrick Winnersbach; Sandra Kraemer; Christian Beckers; Eva Miriam Buhl; Steffen Leonhardt; Rolf Rossaint; Marian Walter; Thomas Breuer; Christian Bleilevens
Journal:  J Clin Med       Date:  2022-06-15       Impact factor: 4.964

2.  Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation.

Authors:  Mariya Negreva; Svetoslav Georgiev; Krasimira Prodanova; Julia Nikolova
Journal:  Cardiol Res       Date:  2016-06-24

3.  Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy.

Authors:  Marek Z Wojtukiewicz; Marta Mysliwiec; Ewa Sierko; Monika Sobierska; Joanna Kruszewska; Alina Lipska; Piotr Radziwon; Stephanie C Tucker; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  2020-06-24       Impact factor: 3.201

4.  Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs.

Authors:  Kenji Rimpo; Aki Tanaka; Masayasu Ukai; Yuichi Ishikawa; Miyuki Hirabayashi; Toshihiro Shoyama
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

5.  Antithrombotic properties of hemofilter coated with polymer having a hydrophilic blood-contacting layer.

Authors:  Masashi Tagaya; Kazunobu Hara; Shunsuke Takahashi; Saki Nagoshi; Hiroki Handa; Shinya Okano; Takuo Murataka
Journal:  Int J Artif Organs       Date:  2018-11-29       Impact factor: 1.595

6.  Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Robin Zenlander; Sebastian Havervall; Maria Magnusson; Jennie Engstrand; Anna Ågren; Charlotte Thålin; Per Stål
Journal:  Sci Rep       Date:  2021-09-09       Impact factor: 4.379

7.  Tissue-engineered vascular microphysiological platform to study immune modulation of xenograft rejection.

Authors:  Tae Hee Kim; Ji-Jing Yan; Joon Young Jang; Gwang-Min Lee; Sun-Kyung Lee; Beom Seok Kim; Justin J Chung; Soo Hyun Kim; Youngmee Jung; Jaeseok Yang
Journal:  Sci Adv       Date:  2021-05-28       Impact factor: 14.136

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.